Stay updated on Long-term Effects of Vedolizumab Subcutaneous Clinical Trial
Sign up to get notified when there's something new on the Long-term Effects of Vedolizumab Subcutaneous Clinical Trial page.

Latest updates to the Long-term Effects of Vedolizumab Subcutaneous Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page footer now includes Revision: v3.3.3. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedA new Revision: v3.3.2 was added to the Record History and Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check51 days agoChange DetectedThe notice regarding potential data delays and government operating status on ClinicalTrials.gov was removed. This notice previously informed users that information on the site might not be up to date.SummaryDifference0.5%

- Check65 days agoChange DetectedThe new screenshot shows cosmetic updates to the Record History page layout and version list presentation, with no substantive edits to trial data or identifiers. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check94 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference10%

- Check101 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Long-term Effects of Vedolizumab Subcutaneous Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Effects of Vedolizumab Subcutaneous Clinical Trial page.